These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 3892344)
1. Insulin treatment of non-insulin-dependent diabetes. Gormley MJ; Andrews WJ; Hannah J; Hadden DR Neth J Med; 1985; 28 Suppl 1():7-11. PubMed ID: 3892344 [No Abstract] [Full Text] [Related]
2. Pharmacodynamics of insulin Lispro in 2 patients with type II diabetes mellitus. Jehle PM; Fussgänger RD; Seibold A; Lüttke B; Böhm BO Int J Clin Pharmacol Ther; 1996 Nov; 34(11):498-503. PubMed ID: 8937933 [TBL] [Abstract][Full Text] [Related]
3. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes. Sinha A; Formica C; Tsalamandris C; Panagiotopoulos S; Hendrich E; DeLuise M; Seeman E; Jerums G Diabet Med; 1996 Jan; 13(1):40-6. PubMed ID: 8741811 [TBL] [Abstract][Full Text] [Related]
4. [Insulin for non-insulin dependent patients with diabetes mellitus]. Razenberg PP Ned Tijdschr Geneeskd; 1986 Aug; 130(34):1514-6. PubMed ID: 3531880 [No Abstract] [Full Text] [Related]
5. Insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus. Effects on blood pressure and glucose tolerance. Levy J; Vandenberg M; Grunberger G Am J Hypertens; 1995 May; 8(5 Pt 1):445-53. PubMed ID: 7662219 [TBL] [Abstract][Full Text] [Related]
6. Added benfluorex in obese insulin-requiring type 2 diabetes. Leutenegger M; Bauduceau B; Brun JM; Guillon-Metz F; Martin C; Nicolino-Peltier C; Richard JL; Vannereau D Diabetes Metab; 1998 Feb; 24(1):55-61. PubMed ID: 9534010 [TBL] [Abstract][Full Text] [Related]
7. Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes. Darmon P; Curtillet C; Boullu S; Laugier A; Dutour A; Oliver C Diabetes Care; 1998 Sep; 21(9):1575. PubMed ID: 9727917 [No Abstract] [Full Text] [Related]
8. Raw vegetable food containing high cyclo (his-pro) improved insulin sensitivity and body weight control. Song MK; Rosenthal MJ; Song AM; Yang H; Ao Y; Yamaguchi DT Metabolism; 2005 Nov; 54(11):1480-9. PubMed ID: 16253637 [TBL] [Abstract][Full Text] [Related]
9. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease. Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882 [TBL] [Abstract][Full Text] [Related]
11. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures]. Tattersall RB Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219 [No Abstract] [Full Text] [Related]
12. Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients. Mayorov AY; Naumenkova IV; Antsiferov MB; Dedov II Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S54-9. PubMed ID: 15955377 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus. Bressler R; Johnson DG Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543 [TBL] [Abstract][Full Text] [Related]
14. Effects of acute starvation on insulin resistance in obese patients with and without type 2 diabetes mellitus. Duska F; Andel M; Kubena A; Macdonald IA Clin Nutr; 2005 Dec; 24(6):1056-64. PubMed ID: 16185788 [TBL] [Abstract][Full Text] [Related]
15. Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non-insulin-dependent diabetes. Sironi AM; Vichi S; Gastaldelli A; Pecori N; Anichini R; Foot E; Seghieri G; Ferrannini E Clin Pharmacol Ther; 1997 Aug; 62(2):194-202. PubMed ID: 9284856 [TBL] [Abstract][Full Text] [Related]
16. Effects of rosiglitazone on body fat distribution and insulin sensitivity in Korean type 2 diabetes mellitus patients. Hwang YC; Lee EY; Lee WJ; Cha BS; Yoon KH; Park KS; Lee MK Metabolism; 2008 Apr; 57(4):479-87. PubMed ID: 18328348 [TBL] [Abstract][Full Text] [Related]
17. Non-insulin-dependent diabetes: 10-year outcome in relation to initial response to diet and subsequent sulfonylurea therapy. Sönksen PH; Lowy C; Perkins JR; Lim HS Diabetes Care; 1984; 7 Suppl 1():59-66. PubMed ID: 6376030 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials. Johnson JL; Wolf SL; Kabadi UM Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835 [TBL] [Abstract][Full Text] [Related]
19. Effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus. Stratton IM; Matthews DR Diabet Med; 1997 Aug; 14(8):709-10. PubMed ID: 9272603 [No Abstract] [Full Text] [Related]
20. Altering therapy of type II diabetes mellitus from insulin to tolazamide increases blood pressure in spite of weight loss. Schmitt JK; Johns SB Am J Hypertens; 1995 May; 8(5 Pt 1):520-3. PubMed ID: 7662230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]